Sept 12 (Reuters) - Eyegate Receives Additional Milestone Payment From Valeant Pharmaceuticals (NYSE:VRX) For Egp EYEG.O
* Granted valeant exclusive commercial and manufacturing rights to company's eyegate ii delivery system, EGP-437 combination product
* Company is eligible to receive milestone payments totaling up to $32.5 million Source text for Eikon: ID:nGNXNBWSHa Further company coverage: EYEG.O